Skip to main content

Table 3 Lifetime costs, life years gained (LYGs), quality-adjusted life years (QALYs), and incremental cost-effectiveness ratio (ICER)

From: Adding rituximab to chemotherapy for diffuse large B-cell lymphoma patients in Indonesia: a cost utility and budget impact analysis

Intervention

Costs (USD)

LYG

QALY

R-CHOP

105,847

6.39

4.06

CHOP

94,931

4.18

3.00

ICER

 

4674/LYG

9280/QALY

  1. Costs are in USD (discounted)
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us